HEALTH CARE USE AND ORAL MEDICATION PATTERNS FOR TYPE 2 DIABETES PATIENTS IN CHINA; THE ROLE OF TRADITIONAL CHINESE MEDICINES

Author(s)

Liu G1, Xu F2
1Peking University, Beijing, China, 2China Pharmaceutical University, Nanjing, China

OBJECTIVES: To investigate the healthcare utilization and cost, focusing on the use of oral anti-diabetic drugs (OADs) for type 2 diabetes patients in China. METHODS: A large scale, prospective, and observational study was conducted in 5 cities of China. Subjects on any OAD were enrolled. The data was collected from longitudinal interviews and diary following-up with the enrolled patients. Primary data information included socio-demographic characteristics, healthcare and medication utilization and costs, laboratory assessments, and quality of life. The baseline interview and 4 times of following-up were conducted within 12 months. HbA1c, fasting blood-glucose and blood lipids were assessed. Multivariable regression and propensity score matching methods were used to control for confounding factors in the study. RESULTS:

Conference/Value in Health Info

2014-09, ISPOR Asia Pacific 2014, Beijing, China

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PRM9

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×